Newsflow expected this quarter :
- Bioequivalence Trial scheduled to commence first QTR 2024 (~FEB)
- The trial only takes 5 days.
- First patient enrolments
- First patient dosing
- Last patient dosing
- Trial results – say 30 days post
- They then plan for first sales under special access in Australia in 2nd QTR 2024 (based on trial results), and move immediately to apply registration with the FDA (US).
Ann: LTR Pharma to List on the ASX, page-127
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.0¢ |
Change
0.015(1.96%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 76.5¢ | 78.5¢ | 74.5¢ | $178.2K | 234.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8660 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.5¢ | 8130 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| LTP (ASX) Chart |